<DOC>
	<DOCNO>NCT00290381</DOCNO>
	<brief_summary>This first proof concept study OC000459 undertaken ass effect compound development inflammatory cytokine model ( nasal allergen challenge model ) validate clinically safe easy conduct . OC000459 compare placebo study . The study randomise , double blind , placebo control , crossover evaluation effect OC000459 cytokine secretion induce nasal allergen challenge . Male subject know history allergic rhinitis screen positive allergen include . After dose OC000459 placebo , nasal allergen challenge perform measurement make nasal fluid . Nasal symptom score also record . Safety parameter monitor throughout .</brief_summary>
	<brief_title>The Effects OC000459 Nasal Mediators</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>1 . Males age 18 50 year history symptom grass pollen relate allergic rhinitis within previous two year . 1 . Medical condition likely affect outcome study . 2 History immunotherapy past 3 year currently immunotherapy treatment course include inhaled local corticosteroid past 28 day . 3 . Any infirmity , disability , geographic location , opinion principal investigator , would limit compliance protocol .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Allergic rhinitis</keyword>
</DOC>